The FDA has granted breakthrough therapy designation to sunvozertinib for patients with locally advanced or metastatic NSCLC with an EGFR exon 20 insertion mutation.
Sunvozertinib Earns FDA Breakthrough Designation for Treatment of Advanced Lung Cancer healthandpharma.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthandpharma.net Daily Mail and Mail on Sunday newspapers.
Hasten's $325M Deal For China Rights To PCSK9 Cholesterol Therapy seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.